Characteristics | N=230 |
Women N (%) | 141 (61) |
Anti-CCP positive N (%) | 189 (82.2) |
Age | 51.4±13.7 |
Time since patient reported first swollen joint, months | 7.1±5.40 |
RAID total | 4.49±2.14 |
RAID pain | 5.32±2.40 |
RAID functional disability | 4.76±2.53 |
RAID fatigue | 4.46±2.77 |
RAID sleep disturbance | 3.90±3.08 |
RAID physical well-being | 4.73±2.40 |
RAID emotional well-being | 3.91±2.44 |
RAID coping | 3.73±2.35 |
Disease Activity Score | 3.46±1.17 |
Erythrocyte sedimentation rate | 24.5±18.6 |
C reactive protein, median (IQR) | 7.00 (3.00, 18.0) |
Swollen joints* | 10.5±7.51 |
Tender joints† | 8.82±7.34 |
Patient global assessment VAS | 49.8±24.4 |
Physician global assessment VAS | 40.6±20.6 |
PROMIS physical function | 39.08.5±8.68 |
Fatigue VAS | 40.4±28.7 |
Joint pain VAS | 47.8±24.1 |
SF-36 physical component summary | 36.3±9.50 |
SF-36 mental component summary | 49.1±10.6 |
Disease Activity Score (0–10), <1.6 (remission), ≥1.6–2.4 (low disease activity), >2.4–3.7 (moderate disease activity), >3.7 (high disease activity). Erythrocyte sedimentation rate (mm/hour, 1–140).
*Assessment of 44 joints (0–44).
†Ritchie Articular Index (0–78).
CCP, cyclic citrullinated peptide; PROMIS, Patient-Reported Outcome Information System (20–100); RAID, Rheumatoid Arthritis Impact of Disease (0–10); SF-36, 36-item Short Form Health Survey (0–100); VAS, Visual Analogue Scale (mm, 0–100).